Walbrook PR, which provides high quality Financial PR and Investor Relations to Small Cap and AIM listed companies, announces that it has acted as Financial PR & Investor Relations advisor to Truspine Technologies plc during their recent listing on the Aquis Stock Exchange (AQSE). Truspine Technologies plc is a medical device company focused on the USD$10.2 billion per annum spinal (vertebral) stabilisation market. Truspine raised gross proceeds of £1.4 million and was valued at £31.6 million on Admission to AQSE.
Truspine is developing unique devices that represent a quantum shift in spinal fixation, fusion & laminoplasty techniques, provide exceptional stabilisation and do not alter bone anatomy by requiring screws, staples or other such attachments which dominate the current technologies. The technology is minimally intrusive, minimally invasive and fully reversable.
Paul McManus, Founder and Managing Director of Walbrook PR commented: “We are very proud to have supported Truspine during its listing on the AQSE exchange. Although an AIM specialist, we work with several AQSE listing companies, including The British Honey Company plc and Greencare Capital plc so we are well placed to advise on this exchange also. We are looking forward to seeing Truspine continue to develop as they work towards commercialisation of their ground-breaking products.”
For more information on Truspine, please go to: http://truspine.org/
For further information please contact:
About Walbrook PR:
Walbrook PR was founded in April 2009 by Paul McManus and focuses on providing high quality Financial PR and Investor Relations to Small Cap and AIM listed companies.
Walbrook PR is ranked 2nd in the AIM Adviser Rankings guide and is ranked 7th by total number of Stock Market listed clients. Walbrook acts for 50 listed companies (41 of them are on AIM) across a wide mix of sectors and is ranked 1st in Healthcare (24 clients), and 4th in Technology, by number of AIM clients. Walbrook PR prides itself on having a strong reputation for working with growing UK Small Cap and AIM listed companies; a proven IR offering, which focuses on the Private Client Investment Management community and the retail investment community; and on having a proactive, hands-on approach from a committed team with full ownership of the business.